"I just have to hope that this abortion should go well": Perceptions, fears, and experiences of abortion clients in Nigeria.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2022
Historique:
received: 13 07 2021
accepted: 10 01 2022
entrez: 7 2 2022
pubmed: 8 2 2022
medline: 4 3 2022
Statut: epublish

Résumé

This qualitative study aimed to examine how abortion clients in Nigeria perceive abortion and explore the role their beliefs and fears play in their care-seeking experiences and interactions with providers. Abortion is severely legally restricted in Nigeria but remains common. We conducted in-depth interviews with 25 people who obtained abortion services through three distinct models of care. We coded interview transcripts and conducted thematic analysis. Clients perceived negative attitudes toward abortion in their communities, though clients' own beliefs were more nuanced. Clients recounted a range of fears, and nearly all mentioned worrying that they might die as a result of their abortion. Despite their concerns, clients relied on social networks and word-of-mouth recommendations to identify providers they perceived as trustworthy and safe. Kind and non-judgmental treatment, clear instructions, open communication, and reassurance of privacy and confidentiality by providers alleviated client fears and helped clients feel supported throughout their abortion process. Within restrictive contexts, the mobilization of information networks, provision of high-quality care through innovative models, and personalization of care to individual needs can assuage fears and contribute to reducing stigma and increasing access to safe abortion services.

Identifiants

pubmed: 35130269
doi: 10.1371/journal.pone.0263072
pii: PONE-D-21-22868
pmc: PMC8820635
doi:

Types de publication

Historical Article Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0263072

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

BJOG. 2016 Aug;123(9):1489-98
pubmed: 26287503
Soc Sci Med. 2015 Sep;141:9-18
pubmed: 26233296
Reprod Health. 2012 Dec 22;9(1):34
pubmed: 23259660
Afr Health Sci. 2010 Sep;10(3):253-65
pubmed: 21327137
Am J Med Qual. 2013 Nov-Dec;28(6):510-8
pubmed: 23585554
Stud Fam Plann. 2018 Mar;49(1):57-70
pubmed: 29508948
J Relig Health. 2019 Dec;58(6):2298-2312
pubmed: 29344842
Reprod Health Matters. 2004 Nov;12(24 Suppl):1-8
pubmed: 15938152
Int J Gynaecol Obstet. 2017 Dec;139 Suppl 1:4-16
pubmed: 29218711
Women Health. 2018 Oct;58(9):967-982
pubmed: 29111958
Best Pract Res Clin Obstet Gynaecol. 2020 Feb;63:87-110
pubmed: 31859163
PLoS One. 2019 May 29;14(5):e0217616
pubmed: 31141550
Int J Gynaecol Obstet. 2006 Nov;95(2):221-6
pubmed: 17010348
PLoS One. 2015 Jan 28;10(1):e0117165
pubmed: 25629900
BMC Womens Health. 2017 Oct 2;17(1):95
pubmed: 28969631
BJOG. 2005 Sep;112(9):1236-42
pubmed: 16101602
PLoS One. 2014 Dec 29;9(12):e115957
pubmed: 25546416
BMC Womens Health. 2019 Apr 8;19(1):55
pubmed: 30961574
Reprod Health. 2020 Oct 27;17(1):164
pubmed: 33109230
Am J Public Health. 2016 Nov;106(11):2071-2075
pubmed: 27631756
BMJ Sex Reprod Health. 2018 May 7;:
pubmed: 29972364
Reprod Health. 2016 Dec 7;13(1):144
pubmed: 27923388
Int Perspect Sex Reprod Health. 2015 Dec;41(4):170-81
pubmed: 26871725
Glob Public Health. 2011;6 Suppl 1:S111-25
pubmed: 21745033
Lancet. 2016 Jul 16;388(10041):258-67
pubmed: 27179755
Sex Reprod Health Matters. 2019 Nov;27(3):1661753
pubmed: 31551027
Lancet. 2006 Nov 25;368(9550):1908-19
pubmed: 17126724
Int J Womens Health. 2018 Jul 12;10:361-366
pubmed: 30034257
Glob Health Action. 2016 Sep 19;9:32193
pubmed: 27649758
Soc Sci Med. 2016 Mar;153:201-9
pubmed: 26921835
J Fam Plann Reprod Health Care. 2017 Jul;43(3):216-221
pubmed: 28330856
Contraception. 2017 Oct;96(4):242-247
pubmed: 28651904
BMJ Sex Reprod Health. 2018 Jul 18;:
pubmed: 30021794
BMJ Glob Health. 2020 Jan 7;5(1):e001814
pubmed: 32133166
Obstet Gynecol. 2006 Jan;107(1):128-35
pubmed: 16394050
J Fam Plann Reprod Health Care. 2015 Jul;41(3):170-80
pubmed: 26106103
PLoS One. 2018 Jan 10;13(1):e0189195
pubmed: 29320513
Perspect Sex Reprod Health. 2016 Dec;48(4):169-177
pubmed: 27037848
PLoS One. 2019 Dec 27;14(12):e0226522
pubmed: 31881041
BMJ. 2017 May 16;357:j2011
pubmed: 28512085
J Womens Health (Larchmt). 2012 Jul;21(7):739-47
pubmed: 22468790

Auteurs

Anna J Katz (AJ)

Ibis Reproductive Health, Oakland, CA, United States of America.
University of California, Berkeley, School of Law, Berkeley, CA, United States of America.

Ana Maria Ramirez (AM)

Ibis Reproductive Health, Oakland, CA, United States of America.

Chiara Bercu (C)

Ibis Reproductive Health, Oakland, CA, United States of America.

Sofia Filippa (S)

Ibis Reproductive Health, Oakland, CA, United States of America.

Osasuyi Dirisu (O)

Ibis Reproductive Health, Oakland, CA, United States of America.

Ijeoma Egwuatu (I)

Generation Initiative for Women and Youth Network, Lagos, Nigeria.

Sybil Nmezi (S)

Generation Initiative for Women and Youth Network, Lagos, Nigeria.

Lucky Palmer (L)

Ipas Nigeria, Lagos, Nigeria.

Sarah E Baum (SE)

Ibis Reproductive Health, Oakland, CA, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH